Ionis to present new analyses from CORE and CORE2 pivotal studies supporting olezarsen for severe hypertriglyceridemia (sHTG) at upcoming congresses
Go back to Ionis to present new analyses from CORE and CORE2 pivotal studies supporting olezarsen for severe hypertriglyceridemia (sHTG) at upcoming congresses| (NASDAQ: IONS) | Delayed: 75.89 +1.77 (2.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $74.12 | 52 Week High | $62.68 | |||
| Open | $74.85 | 52 Week Low | $19.59 | |||
| Day High | $76.56 | P/E | N/A | |||
| Day Low | $74.12 | EPS | $0.00 | |||
| Volume | 1,956,125 | |||||

